High KAT2B expression has been identified as a predictive marker for disease progression to transplantation or mortality in patients with IPF, and was observed to be specifically and progressively upregulated in both individuals who progressed to T1D and those who developed islet cell autoantibodies [29]. This evidence concerns the gene KAT2B and type 1 diabetes mellitus.